Periodic Reporting for period 1 - MucoVac (Unravelling the mode of action of mucosal adjuvants)

Background:Flagellin, a TLR5 agonist, is a leading candidate that is being developed as a potent adjuvant in mucosal vaccines. Interestingly, the mechanism that drive the adjuvant activity of flagellin is influenced by the route of administration. Recent results have suggested...